These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32270033)

  • 1. A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application.
    Ueki R; Uchida S; Kanda N; Yamada N; Ueki A; Akiyama M; Toh K; Cabral H; Sando S
    Sci Adv; 2020 Apr; 6(14):eaay2801. PubMed ID: 32270033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-Based Synthetic Growth Factor Surrogates with Fine-Tuned Agonism*.
    Akiyama M; Ueki R; Yanagawa M; Abe M; Hiroshima M; Sako Y; Sando S
    Angew Chem Int Ed Engl; 2021 Oct; 60(42):22745-22752. PubMed ID: 34142433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.
    Kimoto M; Nakamura M; Hirao I
    Nucleic Acids Res; 2016 Sep; 44(15):7487-94. PubMed ID: 27387284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA aptamer to c-Met inhibits cancer cell migration.
    Ueki R; Sando S
    Chem Commun (Camb); 2014 Nov; 50(86):13131-4. PubMed ID: 25223895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers Binding to c-Met Inhibiting Tumor Cell Migration.
    Piater B; Doerner A; Guenther R; Kolmar H; Hock B
    PLoS One; 2015; 10(12):e0142412. PubMed ID: 26658271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nongenetic Approach for Imaging Protein Dimerization by Aptamer Recognition and Proximity-Induced DNA Assembly.
    Liang H; Chen S; Li P; Wang L; Li J; Li J; Yang HH; Tan W
    J Am Chem Soc; 2018 Mar; 140(12):4186-4190. PubMed ID: 29522674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
    Hughes QW; Le BT; Gilmore G; Baker RI; Veedu RN
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29048375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel DNA sensing system using DNA aptamer inhibited enzymatic activity 1.
    Ikebukuro K; Yoshida W; Sode K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):231-2. PubMed ID: 17150563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides.
    Li N
    J Lab Autom; 2013 Feb; 18(1):77-84. PubMed ID: 22651934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-based affinity labeling of proteins.
    Vinkenborg JL; Mayer G; Famulok M
    Angew Chem Int Ed Engl; 2012 Sep; 51(36):9176-80. PubMed ID: 22865679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplexed aptamers: history, design, theory, and application to biosensing.
    Munzar JD; Ng A; Juncker D
    Chem Soc Rev; 2019 Mar; 48(5):1390-1419. PubMed ID: 30707214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nongenetic Reprogramming of the Ligand Specificity of Growth Factor Receptors by Bispecific DNA Aptamers.
    Ueki R; Atsuta S; Ueki A; Sando S
    J Am Chem Soc; 2017 May; 139(19):6554-6557. PubMed ID: 28459560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
    Haßel SK; Mayer G
    Mol Diagn Ther; 2019 Jun; 23(3):301-309. PubMed ID: 31037641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
    Dausse E; Da Rocha Gomes S; Toulmé JJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):602-7. PubMed ID: 19717337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide-Based Mimetics of Hepatocyte Growth Factor.
    Ueki R; Ueki A; Kanda N; Sando S
    Angew Chem Int Ed Engl; 2016 Jan; 55(2):579-82. PubMed ID: 26592704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-gelatin composite for a trigger release system mediated by oligonucleotide hybridization.
    Soontornworajit B; Srakaew P; Naramitpanich P
    J Biomater Sci Polym Ed; 2014; 25(18):2042-52. PubMed ID: 25297832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Assembled Hybrid Aptamer-Fc Conjugates for Targeted Delivery: A Modular Chemoenzymatic Approach.
    Dickgiesser S; Rasche N; Nasu D; Middel S; Hörner S; Avrutina O; Diederichsen U; Kolmar H
    ACS Chem Biol; 2015 Sep; 10(9):2158-65. PubMed ID: 26131766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic applications of synthetic nucleic acid aptamers.
    Poolsup S; Kim CY
    Curr Opin Biotechnol; 2017 Dec; 48():180-186. PubMed ID: 28582756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffolding along nucleic acid duplexes using 2'-amino-locked nucleic acids.
    Astakhova IK; Wengel J
    Acc Chem Res; 2014 Jun; 47(6):1768-77. PubMed ID: 24749544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.